Biotaitan Molmed Launches Multiplex Ultra-Fast Quantitative PCR Platform for Homecare Testing

Source: 泰坦分子生醫 ( Healthcare+ Expo- booth no.: L602)

Biotaitan Molmed Co., Ltd. is committed to advancing the rapid real-time quantitative PCR (rRT-PCR) platform for point-of-care testing (POCT). By expanding its applications to remote and home-based testing, the platform will facilitate the real-time transmission of medical data and contribute to the development of the healthcare systems. Biotaitan combines rapid PCR with immuno-PCR to obtain multi-omics data, including genomics, transcriptomics, proteomics, and metabolomics information. This feature enables real-time tracking and extensive data collection, combined with artificial intelligence analysis to support precision medicine. This technology will enable faster, and more informed medical decisions, fundamentally changing global health management practices.

AcesoBox is a portable real-time PCR device that uses a patented rapid thermal cycling system and multi-channel optical detection mechanism.

Users samply place the sample prepared through a simple extraction into the patented test tube. Within 5–15 minutes, a report of up to 15 targets will appear on the touch panel. AcesoBox stands out for its multi-target detection, speed, cost-efficiency, and fully automated operation. Providing a one-stop comprehensive solution—from sample input to report generation, it is very suitable for clinical and homecare markets, offering substantial market potential.

In proteomics applications, Biotaitan cooperates with well-known antibody manufacturers in Taiwan to conduct multi-target immuno-PCR detection of cardiac troponins I and T to enable precise assessment of the risk of acute myocardial infarction. Additionally, Biotaitan utilizes precise miRNA quantification combined with AI analysis to detect exosomal miRNA in blood samples from cancer patients. The results significantly improve the accuracy of drug selection and early determine the drug efficacy after first-stage therapy. Based on these proprietary developments, Biotaitan can cooperate with pharmaceutical companies and clinical testing centers to provide custom-developed testing applications according to customer needs, which can be widely used in the fields such as biotechnology medical care, diagnosis, prognosis tracking, and precision medicine.